Principal Statistician at the Institute of Cancer Research Clinical Trials and Statistics Unit (ICR-CTSU)
Joined October 2019
- Tweets20
- Following39
- Followers35
- Likes72
Fay Cafferty retweeted
[3/3]
Robert Huddart, Fay Cafferty and Alison Reid received a Clinical Trial Award to assess circulating serum microRNA as a #biomarker for relapse in Phase 2/3 trial to reduce the burden of standard active surveillance in stage I germ cell tumours.
#CRUKFunded #tyacancer
@robert_huddart | @FayCafferty
Fay Cafferty retweeted
We have an exciting new opportunity for a Principal Statistician to join our team working on cancer #ClinicalTrials. You can find more details about the role, including how to apply, at the link below. #Stats jobs.icr.ac.uk/vacancies/933…
Fay Cafferty retweeted
We're looking for people with #Cancer which has spread to their spine, or their relatives, to join our discussion group on 20th July to help us design our new #ClinicalTrial, SENSE. If you would like to be involved, you can sign up here: eventbrite.com/e/sense-ppi-f… #PPI
ALT An infographic describing the opportunity. It reads: "Can you help with our research? We are designing a trial to investigate the best way of giving radiotherapy to reduce pain for people whose cancer has spread to the spine. We are looking for people with cancer which has spread to their spine, or their relatives, to help us choose the most important questions to ask in the trial. If you would like to help with this research, please join our discussion forum. You can sign up at: bit.ly/3NGukxs. For more information, email: [email protected]."
Fay Cafferty retweeted
🎥 @robert_huddart of @ICR_London discusses TRISST: the cost-effectiveness of alternative imaging and surveillance schedules for testicular seminoma
Watch: 👉ow.ly/Uz4a50NfjGj👈
@ASCO #GU23 #PCSM #BlcSM #kcsm #TSCsm #UroOnc
Fay Cafferty retweeted
New findings from the TRISST trial support #MRI as a cost-effective option to replace potentially harmful CT scans for monitoring early stage #TesticularCancer.
These results were presented on Saturday at
@ASCO #GU23. Learn more👉 bit.ly/3YZHHNm
Fay Cafferty retweeted
First webinar of the year this Friday about the online MSc Statistics for Clinical Trials @ucl starting in Sept 2023.
Join the call if you're interested in studying statistics in clinical trials :-) Share if you know someone who might be.
ucl.ac.uk/population-health-…
@ICTM_UCL
Fay Cafferty retweeted
Interested in #clinicaltrials and innovative trial designs?
Exciting opportunity for an undergraduate student to join the Early Phase and Adaptive Trials Team @ICR_CTSU for a paid summer vacation scholarship!
The ICR's Undergraduate Vacation Scholarship Scheme is now open!
The scheme offers students in the middle years of their degree the chance to gain hands-on #CancerResearch experience for 6 - 8 weeks over the summer.
Find out more and apply now! ⬇️
icr.ac.uk/studying-and-train…
ALT A researcher pipetting in a lab.
Fay Cafferty retweeted
Interested in working in #Cancer #ClinicalTrials? We are currently looking for a Clinical Trials Programme Manager to join our team. For more details visit:
jobs.icr.ac.uk/vacancies/449…
Please get in touch if you want to find out more about this project 👇🏻
And another working with Dr @FayCafferty and Professor @ChristinaBYap on developing guidance and exemplars for a multi-stakeholder approach to estimands in cancer clinical trials:
findaphd.com/phds/project/ge…
Fay Cafferty retweeted
We have 3 PhD opportunities available via the MRC #TrialsMethodology research partnership.
Interested in applying for a funded PhD in trials methodology? Applications are now open for our TMRP Doctoral Training Partnership. 35 projects available across 12 of our partner universities. See the full list here findaphd.com/phds/program/tr… @prw_paula @GilliesKatie @The_MRC
Fay Cafferty retweeted
We are delighted to announce that the full list of projects for our @The_MRC 2023 TMRP Doctoral Training Partnership PhD studentships is now available and open to applications. Deadline: 16 Jan 2023 methodologyhubs.mrc.ac.uk/ab…
New PhD opportunity in cancer clinical trial methodology - work with patients, clinicians and other stakeholders to ensure we ask the right questions (and design trials that provide the answers) using estimands. @ChristinaBYap @ICR_CTSU @MRCNIHRTMRP findaphd.com/phds/project/ge…
Fay Cafferty retweeted
There's still time to apply for our Clinical Trials Programme Manager or Bioinformatician/Translational Statistician roles.
You can find out more details and apply here:
jobs.icr.ac.uk/vacancies/vac…
Fay Cafferty retweeted
My first Tweetorial 🧵 2 year toxicity results of PACE B published here. Big thanks to the 🇬🇧🇨🇦 and🇮🇪collaborators and the 874 men with prostate cancer who made this trial possible thelancet.com/journals/lanon…
Fay Cafferty retweeted
We're currently looking for a Clinical Trials Programme Manager to join our team. For more information about the role and how to apply, please see here: jobs.icr.ac.uk/vacancies/365…
#ICRJobs #ResearchJobs
Fay Cafferty retweeted
Our Parable #ClinicalTrial enrolled its first patient yesterday. Parable aims to investigate the effects of #ProtonBeamTherapy compared to #Radiotherapy in #BreastCancer patients with an increased risk of side effects affecting the heart.
Fay Cafferty retweeted
Read the new plasmaMATCH paper, highlighting the challenges of implementing a platform trial using liquid biopsies to match participants to targeted treatments for #BreastCancer: trialsjournal.biomedcentral.…
Fay Cafferty retweeted
Fewer scans, less imaging radiation- equivalent results What’s not to like?
Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST) @MRCCTU @FayCafferty ascopubs.org/doi/full/10.120…
Fay Cafferty retweeted
Are MRI #scans as effective as CT scans in detecting testicular #cancer relapse? How often should men have scans post-surgery?
The TRISST #Trial found that relapses can be detected at an early-stage with less scans & using MRI
@FayCafferty @CRUKresearch
bit.ly/3Jq98IH